Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 06. September 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9553  Previews Next
   
   Articles 1 - 20 / 191059  
   
Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.
Urol Oncol
Corvino R, Basile G, Santarelli V, Asero V, De Berardinis E, Sciarra A, Vittori L, Abu-Ghanem Y, Nair R, Khan MS, Thurairaja R, Barod R, Krajewski W, Laszkiewicz J, Albisinni S, Mori K, Guerrero-Ramos F, D'Andrea D, Gallioli A, Laukhtina E, Suleja A, Grobet-Jeandin E, Mari A, Mertens LS, Moschini M, De Angelis M, Scillipoti P, Soria F, Bosio A, Teoh J, Claps F, Amodeo A, , Contieri R, Subiela D, Tagalos A, Tully KH, Pichler R, Antonelli A, Bertolo R, Veccia A, Malandra S, Hurle R, Sormani F, Crocetto F, Mayr R, Porreca A, Simone G, Tuderti G, Rocco B, Simonato A, Simonato FA, Marcq G, Gontero P, Tian Z, Karakiewicz P, Chung BI, Pradere B, Del Giudice F.
PMID: 42701052 [PubMed - as supplied by publisher]


Long-term exposure to trihalomethanes in drinking water and risk of liver and kidney cancer: a population-based cohort study.
Environ Int
Helte E, Säve-Söderbergh M, Åkesson A.
PMID: 42700668 [PubMed - as supplied by publisher]


Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [(177)Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.
Biomed Pharmacother
Obeid K, Konijnenberg M, Bezverkhniaia E, Maina T, Nock BA, Tolmachev V, Kanellopoulos P, Orlova A.
PMID: 42700618 [PubMed - as supplied by publisher]


Integrative omics profiling of CRELD2 in ccRCC: a nexus of genetics, prognosis, and tumor microenvironment.
Inflamm Res
Liu S, Zhou Y, Fan L, Wang Y, Qu L, Zhou W.
PMID: 42700259 [PubMed - indexed for MEDLINE]


Risk of bone metastases on [(18)F]NaF PET/CT in 734 patients with newly diagnosed prostate cancer.
Eur J Nucl Med Mol Imaging
Madsen C, Zacho HD, Bisbjerg R, Fuglø D, Østergren PB.
PMID: 42700249 [PubMed - as supplied by publisher]


Feasibility of laparoscopic radical prostatectomy initiation by a surgeon with limited open surgery experience: A single-surgeon series with prior laparoscopic background.
Medicine (Baltimore)
Senoglu Y, Ediz E, Dilek IE, Ekici N, Baba D.
PMID: 42700081 [PubMed - indexed for MEDLINE]


Renal small cell neuroendocrine carcinoma: a case report and literature review.
Int J Surg Case Rep
Wei C, Wang X, Shayiremu D, Ren C.
PMID: 42699921 [PubMed]


Renal cell carcinoma in a child presenting with chronic gross hematuria: A rare case report with diagnostic and surgical insights.
Urol Case Rep
Harikatang AD, Siregar S, Majid GI.
PMID: 42699517 [PubMed]


Challenges in the initial diagnosis of colon carcinoma from symptoms of a bladder and colon fistula: a case report.
Int J Surg Case Rep
Duan JH, Wu YY, Wang WB, Zhang YP, Yang LP, Deng CH.
PMID: 42699440 [PubMed]


The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development.
Front Cell Dev Biol
Mann TJ, Becker TM, Roberts TL, de Souza P, Lock JG.
PMID: 42698629 [PubMed]


Cancer Expenditures and Mortality Trends in Brazil: An Ecological Population-Level Time-Series Analysis, 2008-2023.
Cancer Med
Fonseca LS, Pires LP, Alencar LMR, Ricci-Junior E, Santos-Oliveira R.
PMID: 42698132 [PubMed - indexed for MEDLINE]


Prostate surgery outcomes in patients presenting with and without a urethral catheter: a long-term comparative study.
World J Urol
Segal N, Ehrlich Y, Lifshitz D, Darawsha AE.
PMID: 42698027 [PubMed - indexed for MEDLINE]


[Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence].
Urologie
Gakis G, Vom Dorp F.
PMID: 42697960 [PubMed - as supplied by publisher]


Distinct Prognostic Roles of Grade Group and Intraductal Carcinoma of the Prostate in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Int J Urol
Ikeda J, Taniguchi H, Inoue M, Masuo Y, Nakamoto T, Taguchi M, Shimada S, Mishima T, Yanishi M, Uchida K, Kinoshita H.
PMID: 42697858 [PubMed - indexed for MEDLINE]


Reply to Francesco Di Bello, Andrea Gallioli, Joan Palou, and Alberto Breda's Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12.
Eur Urol Oncol
Contieri R, Hurle R.
PMID: 42697826 [PubMed - as supplied by publisher]


Diagnostic accuracy of Chronic Kidney Disease Epidemiology Collaboration 2021 and Janowitz-estimated glomerular filtration rate for identifying renal dysfunction compared with 99mTc-DTPA in patients with locally advanced cervical cancer.
Int J Gynecol Cancer
Mora-Soto N, Viveros-Carreño D, Peralta JA, Rodríguez J, Vieira S, Varela H, Núñez M, Pareja R.
PMID: 42697807 [PubMed - as supplied by publisher]


An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial.
Lancet Oncol
Bourke L, Rosario DJ, Reale S, Ibeggazene S, Innes A, Scope A, Price G, Taylor S, Steed L, Sutton E, Stokes J, Hewison J, Morrissey D, Doherty P, Brown J, Meads D, O'Dwyer JL, Deniszczyc D, Greenfield DM, Mason M, Collinson M, Farrin A, STAMINA investigators.
PMID: 42697217 [PubMed - as supplied by publisher]


The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy.
Int J Biol Sci
He K, Zhao Z, Bai J, Lu T, Hu Y, He X, Wei F, Zhang Y, Gu Y, Shi Z, Meng X, Wang F, Shi C, Qin W, Zhang K, Xie Q, Yang L.
PMID: 42694990 [PubMed - indexed for MEDLINE]


Inflammatory bowel disease and prostate cancer: from epidemiological controversy to mechanistic hypotheses.
Front Immunol
Yu T, Zhang L, Li D, Wang Y.
PMID: 42694773 [PubMed - indexed for MEDLINE]


Urinary microbiota in bladder cancer: insights into pathogenesis, diagnosis, and therapeutic potential.
Front Cell Infect Microbiol
Sheng Z, Zhu J, Sun J, Zeng S, Ding J, Zhang Z.
PMID: 42694772 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 191059    Page 1 of 9553  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1